Richard L. Gelfond, CEO of IMAX Corporation, has been a consistent seller of company stock over the past several months, with no open-market purchases recorded in his recent SEC Form 4 filings. Across 51 total transactions in IMAX, he has sold approximately $21.3 million worth of shares while acquiring roughly $15.3 million in value—almost entirely through option exercises and equity grants rather than cash purchases. The pattern is unambiguous: every open-market transaction involving his own capital has been a sale, with zero "P" (purchase) codes appearing in the data.
The most intense selling occurred in April 2026, when Gelfond executed a series of large same-day conversions and sales. On April 10, he sold $5.1 million in IMAX shares after converting $4.2 million in derivative securities; on April 13, he sold $3.6 million following a $3.1 million conversion; and on April 17, he sold $1.3 million against a $1.1 million conversion. Smaller sales on April 2, April 6, April 14, April 15, and April 27 ranged from roughly $257,000 to $583,000, each paired with a corresponding conversion of similar value. Earlier, on March 10, he sold $4.9 million in stock after converting $3.8 million in options. These transactions show a clear pattern of exercising options and immediately liquidating the resulting shares, a mechanical approach that maximizes cash realization rather than building or maintaining a larger equity stake.
The only non-sale activity in the recent window consists of standard corporate events: a March 7 equity grant valued at $0, a $6.5 million tax-withholding transaction (code "F") on the same date, and a smaller $727,000 tax withholding on January 2. These are automatic consequences of vesting awards, not discretionary trades. In total, Gelfond's recent filings reveal a CEO who is steadily monetizing his IMAX holdings—selling into strength across multiple sessions in March and April—while showing no appetite for adding shares at current prices.
AI-assisted summary